The objective was to investigate the effects of vaginal valproic acid or resveratrol with vitamin D3 in Pentravan®, on deep endometriosis-associated pain in patients treated with gestrinone. They potentiated the effects of gestrinone in the first month of treatment; however, this difference disappeared in the subsequent months.

The effects of Myodesin™ on uterine volume and pain scores were investigated in a group of patients with leiomyoma and endometriosis. Miodesin treatment increased the efficacy of Gestrinone to reduce pelvic pain and uterine volume in patients with endometriosis and leiomyoma.

In this study, conditioners using blueberry, raspberry, cranberry and resveratrol in TrichoCond® were developed. Two out of the seven presented significative sun protection. Three samples of treated hair presented suitable results in maintenance of the cystine content after sun exposure. Conditioners containing resveratrol showed better protection against solar radiation.

The objective of this study was to evaluate the stability of 7 commonly used APIs ingredients compounded in SyrSpend SF PH4. The beyond-use date of the final products (active pharmaceutical ingredient + vehicle) was at least 90 days for all suspensions with regard to both temperatures.

This study aimed to develop a device to produce transdermal patches in compounding pharmacies. Tadalafil could permeate to the viable epidermis and dermis (5.7%). The created device produced homogeneous patches of tadalafil, showing feasibility in individualized therapy for the treatment of erectile dysfunction.

This article aims to explore some of the basics on orodispersible film and the main possible preparations to be developed in compounding pharmacies worldwide.

The objective of this study was to determine the variation in content of 74 different APIs and compare it with existing literature on the content uniformity of extemporaneous prepared capsules. Compounded oral liquids show little variation, appearing to be a suitable alternative when compounding individualized medications for patients.

The objective of this study was to evaluate the stability of 10 commonly used APIs compounded in oral suspensions using SyrSpend SF PH4. The beyond-use date of the final products (APIs + vehicle) was at least 90 days for all suspensions with regard to both temperatures.

The objective of this study was to assess oral suspensions with SyrSpend SF based on tablets or capsules as a suitable alternative for using raw APIs. Based on this study, a wide range of excipients do not seem to impact the beyond-use date of different APIs compounded in SyrSpend SF.

In this study, the blood concentrations of enrofloxacin administered transdermally to 3 different reptilian species at 50 mg/kg were determined. Although the values were unquantifiable, this study confirms the absorption of enrofloxacin.